Current indications of polyvalent immunoglobulins;Indications actuelles des immunoglobulines polyvalentes

Bulletin de l'Academie Nationale de Medecine

Volumn 196, Issue 1, 2012, Pages 49-61

  Magy, Laurent ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Chronic inflammatory demyelinating peripheral nervous system diseaeses; CNS; Common variable immunodeficiency; Demyelinating autoimmune diseases; Immunoglobulins; Intravenous; Polyradiculoneuropathy

Indexed keywords

EID: 84870557704     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)31880-1     Document Type: Article

References (37)

1. KUITWAARD K., VAN DEN BERG L. H., VERMEULEN M., BRUSSE E., CATS E. A., VAN der KOOI A. J. et al. - Randomised controlled trial comparing two different intravenous immunoglobulins in chronic inflammatory demyelinating polyradiculoneuropathy. J. Neurol. Neurosurg. Psychiatry, 2010 Dec, 81(12), 1374-9.
2. BUSSE P. J., RAZVI S., CUNNINGHAM-RUNDLES C. - Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J. Allergy Clin. Immunol, 2002 Jun., 109(6), 1001-4. (Pubitemid 34634312)
3. EIJKHOUT H. W., VAN der MEER J. W., KALLENBERG C. G., WEENING R. S., VAN DISSEL J. T., SANDERS L. A. et al. - The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann. Intern. Med., 2001 Aug. 7, 135(3), 165-74. (Pubitemid 32738310)
4. QUARTIER P., DEBRE M., DE BLIC J., DE SAUVERZAC R., SAYEGH N., JABADO N., et al. - Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: A retrospective survey of 31 patients. J Pediatr, 1999 May, 134(5), 589-96. (Pubitemid 30180599)
5. GARDULF A., HAMMARSTROM L., SMITH C. I. - Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet, 1991 Jul. 20, 338(8760), 162-6.
6. OCHS H. D., GUPTA S., KIESSLING P., NICOLAY U, BERGER M., SUBCUTANEOUSIG G. S. G. - Safely and efficacy of self-Administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. J. Clin. Immunol., 2006 May, 26(3), 265-73. (Pubitemid 43901655)
7. IMBACH P., BARANDUN S., D'APUZZO V., BAUMGARTNER C, HIRT A., MORELL A., et al. - High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet, 1981 Jun6, 1(8232), 1228-31.
8. MAGY L., VALLAT J. M. - Evidence-based treatment of chronic immune-mediated neuropathies. Expert Opin. Pharmacolher., 2009 Aug., 10(11), 1741-54.
9. WILLISON H. J., YUKI N. - Peripheral neuropathies and anti-glycolipid antibodies. Brain, 2002 Dec,. 125(Pt 12), 2591-625. (Pubitemid 35423511)
10. RAPHAEL J. C., CHEVRET S., HUGHES R. A., ANNANE D. - Plasma exchange for Guillain-Barre syndrome. Cochrane Database Syst. Rev., 2002, (2), CD001798.
11. VAN DER MÈCHE F. G., SCHMITZ P. I. - A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N. Engl. J. Med, 1992 Apr. 23, 326(17), 1123-9.
12. DYCK P. J., LAIS A. C., OHTA M., BASTRON J. A., OKAZAKI H., GROOVER R. V. - Chronic inflammatory polyradiculoneuropathy. Mayo. Clin. Proc, 1975, 50, 621-37.
13. French CI DP Study Group - Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy. J. Neurol. Neurosurg. Psychiatry, 2008 Feb., 79(2), 115-8.
14. VALLAT J. M., SOMMER C, MAGY L. - Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol, 2010 Apr., 9(4), 402-12.
15. DYCK P. J., O'BRIEN P. C., OVIATT K. F., DINAPOLI R. P., DAUBE J. R., BARTLESON J. D. et al. - Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann. Neurol., 1982, 11, 136-41. (Pubitemid 12162978)
16. DYCK P. J., DAUBE J., O'BRIEN P., PINEDA A., LOW P. A., WINDEBANK A. J. et al. - Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. J. Engl. J. Med., 1986 Feb. 20, 314(8), 461-5. (Pubitemid 16161945)
17. HAHN A. F., BOLTON C. F., ZOCHODNE D., FEASBY T. E. - Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebocontrolled, cross-over study. Brain, 1996 Aug., 119(Pt4), 1067-77. (Pubitemid 26300709)
18. HUGHES R., BENSA S., WILLISON H., VAN DEN BERGH P., COMI G., ILLA I. et al. - Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann. Neurol, 2001 Aug., 50(2), 195-201. (Pubitemid 32738144)
19. MENDELL J. R., BAROHN R. J., FREIMER M. L., KISSEL J. T., KING W., NAGARAJA H. N. et al. - Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology, 2001 Feb. 27, 56(4), 445-9. (Pubitemid 32172866)
20. VERMEULEN M., VAN DOORN P. A., BRAND A., STRENGERS P. F., JENNEKENS F. G., BUSCH H. F. - Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: A double blind, placebo controlled study. J. Neurol. Neurosurg. Psychiatry, 1993 Jan., 56(1), 36-9. (Pubitemid 23062977)
21. HUGHES R. A., DONOFRIO P., BRIL V, DALAKAS M. C, DENG C, HANNA K. et al. - Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): A randomised placebocontrolled trial. Lancet Neurol., 2008 Feb., 7(2), 136-44.
22. CARPO M., CAPPELLARI A., MORA G, PEDOTTI R., BARBIERI S., SCARLATO G. et al. - Deterioration of multifocal motor neuropathy after plasma exchange. Neurology, 1998 May, 50(5), 1480-2. (Pubitemid 28240378)
23. DONAGHY M., MILLS K. R., BONIFACE S. J., SIMMONS J., WRIGHT I., GREGSON N., et al. - Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin, Neurol. Neurosurg. Psychiatry, 1994 Jul., 57(7), 778-83. (Pubitemid 24214955)
24. AZULAY J. P., BLIN O., POUGET J., BOUCRAUT J., BILLE-TURC F., CARLES G. et al. - Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: A double-blind, placebo-controlled study. Neurology, 1994 Mar., 44(3 Pt 1), 429-32.
25. FEDERICO P., ZOCHODNE D. W., HAHN A. F., BROWN W. F., FEASBY T. E. - Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology, 2000 Nov. 14, 55(9), 1256-62.
26. LÉGER J. M., CHASSANDE B., MUSSET L., MEININGER V., BOUCHE P., BAUMANN N. - Intravenous immunoglobulin therapy in multifocal motor neuropathy: A double-blind, placebo-controlled study. Brain, 2001 Jan, 124(Pt 1), 145-53. (Pubitemid 32055996)
27. VAN DEN BERG L. H., KERKHOFF H., OEY P. L., FRANSSEN H., MOLLEE I., VERMEULEN M. et al. - Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: A double blind, placebo controlled study. J. Neurol. Neurosurg. Psychiatry, 1995 Sep, 59(3), 248-52.
28. VUCIC S., BLACK K. R., CHONG P. S., CROS D. - Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg. Neurology, 2004 Oct. 12, 63(7), 1264-9. (Pubitemid 39350028)
29. BAIN P. G., MOTOMURA M., NEWSOM-DAVIS J., MISBAH S. A., CHAPEL H. M., LEE M. L. et al. - Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Neurology, 1996 Sep, 47(3), 678-83.
30. BARKER R. A., MARSDEN C. D. - Successful treatment of stiff man syndrome with intravenous immunoglobulin. J. Neurol. Neurosurg. Psychiatry, 1997 Apr, 62(4), 426-7. (Pubitemid 27199131)
31. COMI G., ROVERI L., SWAN A., WILLISON H., BOJAR M., ILLA I. et al. - A randomised controlled trial of intravenous immunoglobulin in lgM paraprotein associated demyelinating neuropathy. J. Neurol., 2002, 249(10), 1370-7. (Pubitemid 35217657)
32. GAJDOS P., TRANCHANT G, CLAIR B., BOLGERT F., EYMARD B., STOJKOVIC T. et al. - Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: A randomized doubleblind clinical trial. Arch. Neurol., 2005 Nov, 62(11), 1689-93. (Pubitemid 41626664)
33. FRAUGER E., GRASSI J., PRADEL V, BORNET G, ROUBY F, DELORME J. et al. - Use of intravenous immunoglobulins in clinical practice: data from three French university hospitals. Fundam. Clin. Pharmacol., 2011 Dec, 25(6), 753-61.
34. KUITWAARD K., DE GELDER J., TIO-GILLEN A. P., HOP W. G, VAN GELDER T., VAN TOORENENBERGEN A. W. et al. - Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barre syndrome. Ann. Neurol., 2009 Nov., 66(5), 597-603.
35. RMC Trial Group - Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): A pilot, multicentre study. Lancet Neurol., 2009 Feb, 8(2), 158-64.
36. HARBO T., ANDERSEN H., HESS A., HANSEN K., SINDRUP S. H., JAKOBSEN J. - Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: A randomized, singleblinded cross-over trial. Eur. J. Neurol., 2009 May, 16(5), 631-8.
37. HARBO T., ANDERSEN H., JAKOBSEN J. - Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy. Neurology, 2010 Oct. 12, 75(15), 1377-80.